Drug General Information
Drug ID	D05ICF
Former ID	DNC014569
Drug Name	1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526092]
Structure		Download 2D MOL 3D MOL
Formula	C16H14N2O2
Canonical SMILES	CC1=CC=C(C=C1)N2C(=O)N(C2=O)C3=CC=C(C=C3)C
InChI	1S/C16H14N2O2/c1-11-3-7-13(8-4-11)17-15(19)18(16(17)20)14-9-5-12(2)6-10-14/h3-10H,1-2H3
InChIKey	AZZFGWWOGRBVOV-UHFFFAOYSA-N
PubChem Compound ID	3492365
Target and Pathway
Target(s)	Trypsin	Target Info	Inhibitor	[526092]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Pancreatic secretion
	Protein digestion and absorption
	Influenza A
Reactome	Activation of Matrix Metalloproteinases
	Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways	Activation of Matrix Metalloproteinases
References
Ref 526092	Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.
Ref 526092	Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.